These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 8593172

  • 1. Synthesis and in vitro activities of highly potent and selective tripeptide antagonists of the neurokinin NK-1 receptor.
    Caliendo G, Greco G, Grieco P, Perissutti E, Santagada V, Calignano A, Mancuso F, Novellino E.
    Farmaco; 1995 Nov; 50(11):755-9. PubMed ID: 8593172
    [Abstract] [Full Text] [Related]

  • 2. Modification of the potent peptide FK888 with unusual aminoacids: effects on activity on neurokinin receptors.
    Caliendo G, Greco G, Grieco P, Perissutti E, Santagada V, Calignano A, Mancuso F, Novellino E.
    Farmaco; 1996 Mar; 51(3):197-201. PubMed ID: 8688142
    [Abstract] [Full Text] [Related]

  • 3. Synthesis and biological activity of tripeptide FR113680 analogues containing unconventional amino acids.
    Caliendo G, Calignano A, Grieco P, Mancuso F, Perissutti E, Santini A, Santagada V.
    Biopolymers; 1995 Oct; 36(4):409-14. PubMed ID: 7578938
    [Abstract] [Full Text] [Related]

  • 4. Activity of cyclic pseudopeptide antagonists at peripheral tachykinin receptors.
    Patacchini R, Quartara L, Astolfi M, Goso C, Giachetti A, Maggi CA.
    J Pharmacol Exp Ther; 1995 Mar; 272(3):1082-7. PubMed ID: 7891319
    [Abstract] [Full Text] [Related]

  • 5. MEN 11420 (Nepadutant), a novel glycosylated bicyclic peptide tachykinin NK2 receptor antagonist.
    Catalioto RM, Criscuoli M, Cucchi P, Giachetti A, Gianotti D, Giuliani S, Lecci A, Lippi A, Patacchini R, Quartara L, Renzetti AR, Tramontana M, Arcamone F, Maggi CA.
    Br J Pharmacol; 1998 Jan; 123(1):81-91. PubMed ID: 9484857
    [Abstract] [Full Text] [Related]

  • 6. Synthesis and in vitro activities of NK-1 antagonists derived from L-tryptophan.
    Caliendo G, Fiorino F, Grieco P, Perissutti E, Santagada V, Calignano A, Mancuso F, Albrizio S.
    Farmaco; 1997 Oct; 52(10):589-93. PubMed ID: 9507670
    [Abstract] [Full Text] [Related]

  • 7. Pharmacological characterization of ZD6021: a novel, orally active antagonist of the tachykinin receptors.
    Rumsey WL, Aharony D, Bialecki RA, Abbott BM, Barthlow HG, Caccese R, Ghanekar S, Lengel D, McCarthy M, Wenrich B, Undem B, Ohnmacht C, Shenvi A, Albert JS, Brown F, Bernstein PR, Russell K.
    J Pharmacol Exp Ther; 2001 Jul; 298(1):307-15. PubMed ID: 11408556
    [Abstract] [Full Text] [Related]

  • 8. Design and synthesis of dimeric analogs of neurokinin A and B: effect of dimerization of COOH-terminal heptapeptides on receptor selection.
    Sakaguchi K, Kodama H, Matsumoto H, Yoshida M, Takano Y, Kamiya H, Waki M, Shimohigashi Y.
    Pept Res; 1989 Jul; 2(5):345-51. PubMed ID: 2485210
    [Abstract] [Full Text] [Related]

  • 9. MEN15596, a novel nonpeptide tachykinin NK2 receptor antagonist.
    Cialdai C, Tramontana M, Patacchini R, Lecci A, Catalani C, Catalioto RM, Meini S, Valenti C, Altamura M, Giuliani S, Maggi CA.
    Eur J Pharmacol; 2006 Nov 07; 549(1-3):140-8. PubMed ID: 16979621
    [Abstract] [Full Text] [Related]

  • 10. Pharmacology of MEN 11467: a potent new selective and orally- effective peptidomimetic tachykinin NK(1) receptor antagonist.
    Cirillo R, Astolfi M, Conte B, Lopez G, Parlani M, Sacco G, Terracciano R, Fincham CI, Sisto A, Evangelista S, Maggi CA, Manzini S.
    Neuropeptides; 2001 Nov 07; 35(3-4):137-47. PubMed ID: 11884203
    [Abstract] [Full Text] [Related]

  • 11. In vitro and in vivo characterization of MDL 105,212A, a nonpeptide NK-1/NK-2 tachykinin receptor antagonist.
    Kudlacz EM, Shatzer SA, Knippenberg RW, Logan DE, Poirot M, van Giersbergen PL, Burkholder TP.
    J Pharmacol Exp Ther; 1996 May 07; 277(2):840-51. PubMed ID: 8627566
    [Abstract] [Full Text] [Related]

  • 12. Characterization of species-related differences in the pharmacology of tachykinin NK receptors 1, 2 and 3.
    Leffler A, Ahlstedt I, Engberg S, Svensson A, Billger M, Oberg L, Bjursell MK, Lindström E, von Mentzer B.
    Biochem Pharmacol; 2009 May 01; 77(9):1522-30. PubMed ID: 19426690
    [Abstract] [Full Text] [Related]

  • 13. Oxytocin release from the rat neurohypophysis into the blood: effects of tachykinin NK-1 and NK-2 receptors agonists and antagonists.
    Juszczak M, Boczek-Leszczyk E.
    J Physiol Pharmacol; 2008 Sep 01; 59(3):553-62. PubMed ID: 18953097
    [Abstract] [Full Text] [Related]

  • 14. Novel triple neurokinin receptor antagonist CS-003 strongly inhibits neurokinin related responses.
    Tsuchida H, Takahashi S, Nosaka E, Mukaiyama O, Yamashita M, Morimoto K.
    Eur J Pharmacol; 2008 May 31; 586(1-3):306-12. PubMed ID: 18353309
    [Abstract] [Full Text] [Related]

  • 15. Vasopressin release from the rat hypothalamo-neurohypophysial system: effects of tachykinin NK-1 and NK-2 receptors agonists and antagonists.
    Juszczak M.
    Neuro Endocrinol Lett; 2005 Aug 31; 26(4):367-72. PubMed ID: 16136007
    [Abstract] [Full Text] [Related]

  • 16. Evidence for adrenergic and tachykinin activity in venom of the stonefish (Synanceja trachynis).
    Hopkins BJ, Hodgson WC, Sutherland SK.
    Toxicon; 1996 May 31; 34(5):541-54. PubMed ID: 8783449
    [Abstract] [Full Text] [Related]

  • 17. Comparison of the effects of (+/-) CP 96,345 and L-668,169 on neurokinin receptor mediated responses in rat and guinea-pig isolated tissues.
    Razzaque Z, Longmore J.
    Neuropeptides; 1993 Sep 31; 25(3):169-74. PubMed ID: 7504215
    [Abstract] [Full Text] [Related]

  • 18. Pharmacological characterization of SR 142801: a new non-peptide antagonist of the neurokinin NK-3 receptor.
    Nguyen-Le XK, Nguyen QT, Gobeil F, Pheng LH, Emonds-Alt X, Brelière JC, Regoli D.
    Pharmacology; 1996 May 31; 52(5):283-91. PubMed ID: 8807672
    [Abstract] [Full Text] [Related]

  • 19. Beta-methyl substitution of cyclohexylalanine in Dmt-Tic-Cha-Phe peptides results in highly potent delta opioid antagonists.
    Tóth G, Ioja E, Tömböly C, Ballet S, Tourwé D, Péter A, Martinek T, Chung NN, Schiller PW, Benyhe S, Borsodi A.
    J Med Chem; 2007 Jan 25; 50(2):328-33. PubMed ID: 17228874
    [Abstract] [Full Text] [Related]

  • 20. Effect of melatonin on the vasopressin secretion as influenced by tachykinin NK-1 receptor agonist and antagonist: in vivo and in vitro studies.
    Juszczak M, Boczek-Leszczyk E, Stempniak B.
    J Physiol Pharmacol; 2007 Dec 25; 58(4):829-43. PubMed ID: 18195491
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.